MATCH Trial
EAY191 – A3
Palbociclib and Binimetinib in RAS-Mutant Cancers: A ComboMATCH Treatment Trial
EAY191 – S3 (JIT)
Phase 2 Study of Paclitaxel + Ipatasertib in Taxane-Refractory Participants with AKT-Altered Advanced Non-Breast Solid Tumors.
EAY191-A6 (JIT Trial)
FOLFOX in Combination with Binimetinib as 2nd Line Therapy for Patients with Advanced Biliary Tract Cancers with MAPK Pathway Alterations: A ComboMATCH Treatment Trial
EAY191-COMBOMATCH
Molecular Analysis for Combination Therapy Choice (ComboMATCH)
